Pyxis Oncology granted FDA Fast Track Designation for PYX-201 monotherapy in patients with recurrent or...

Hansoh Pharma’s HS-20093 receives Breakthrough Therapy Designation from NMPA for Osteosarcoma

Akeso highlights collaboration between its partner Summit Therapeutics and Pfizer to explore Ivonescimab in combination...

MEDSIR & Debiopharm announce the first patient dosed in the WIN-B trial exploring the combination...

First patient dosed in a Phase 3 clinical study of anti-HER2 biparatopic ADC JSKN003 for...

OS Therapies forms subsidiary OS Drug Conjugates and initiates review of strategic options for its...